Skip to main content
SpringerLink
Log in

Human skin organoids are valid models of mpox virus infection

  • Research Briefing
  • Published:

From Nature Microbiology

View current issue Submit your manuscript

Human skin organoids are susceptible to mpox virus infection and support infectious virus production. Treatment of infected skin organoids with the antiviral drug tecovirimat can inhibit infectious virus production and prevent host transcriptome rewiring. Thus, skin-organoid-based models are robust for studying mpox virus infection and testing therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Skin organoids support MPXV infection and respond to tecovirimat treatment.

References

  1. Americo, J. L., Earl, P. L. & Moss, B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc. Natl Acad. Sci. USA 120, e2220415120 (2023). This paper reports the virulence differences of mpox virus clades I and II.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Li, P. et al. Clinical features, antiviral treatment, and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks. J. Infect. Dis. 228, 391–401 (2023). A systematic review article describing the clinical features of patients with mpox.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Rosa, R. B. et al. In vitro and in vivo models for monkeypox. iScience 26, 105702 (2023). A review article that presents the current experimental models for MPXV research.

    Article  CAS  PubMed  Google Scholar 

  4. Lee, J. et al. Hair-bearing human skin generated entirely from pluripotent stem cells. Nature 582, 399–404 (2020). This paper reports a protocol on how to generate human skin organoids from pluripotent stem cells.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sherwat, A. et al. Tecovirimat and the treatment of monkeypox — past, present, and future considerations. N. Engl. J. Med. 387, 579–581 (2022). This article provides an overview of tecovirimat for treating smallpox and mpox diseases.

    Article  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Li, P. et al. Mpox virus infection and drug treatment modelled in human skin organoids. Nat. Microbiol. https://doi.org/10.1038/s41564-023-01489-6 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Human skin organoids are valid models of mpox virus infection. Nat Microbiol 8, 1950–1951 (2023). https://doi.org/10.1038/s41564-023-01490-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41564-023-01490-z

  • Springer Nature Limited

Search

Navigation